Accord Clinical Research Announces Ulcerative Proctitis Research Studies in Daytona Beach, Florida

Deland, FL, May 21, 2010 --(PR.com)-- Accord Clinical Research, a privately owned research facility, located in Port Orange, Florida, announces their latest research study to test investigational treatment options for those already diagnosed with ulcerative proctitis. “We are very pleased to begin the systemic evaluation of our research studies to help find a viable investigational treatment solution to those suffering from ulcerative proctitis,” said Dr Ricci, MD. “We believe that these research studies will build significantly on the data generated by other studies conducted on investigational treatment options for U.P.," Dr. Ricci conducts research with Accord Clinical Research and is currently the Medical Director.

The research studies will enroll those already diagnosed with ulcerative proctitis, which includes symptoms like diarrhea, bleeding, persistent urge to empty the bowel whether or not a stool is present, mucus discharge, rectal pain and constipation. In order to participate in the studies volunteers must be diagnosed with ulcerative proctitis. Accord Clinical Research will not take volunteers who:

- have any evidence or treatment of malignancy within the previous 5 years,
- have a history of alcohol or substance abuse within the previous 5 years,
- have used an investigatory drug or participated in an investigatory study within 30 days of the screening,
- are pregnant, or
- are breast-feeding.

Accord Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. For more information regarding participation in our research studies, contact Accord Clinical Research at 386.760.7272, or at www.AccordClinical.com.

###